hospira pentamidine isethionate for injection pentamidine isetionate 300mg powder for injection vial
hospira australia pty ltd - pentamidine isetionate -
hospira ketamine injection ketamine (as hydrochloride) 200 mg/2 ml concentrated solution for injection vial
hospira australia pty ltd - ketamine hydrochloride -
hospira amikacin injection amikacin (as sulfate) 500mg/2ml solution for injection vial
hospira australia pty ltd - amikacin -
hospira cisplatin injection 50mg/50ml vial
hospira australia pty ltd - cisplatin, quantity: 1 mg/ml - injection, intravenous infusion - excipient ingredients: hydrochloric acid; water for injections; sodium hydroxide; sodium chloride; mannitol - cancer chemotherapeutic drug - details of indications do not appear in the leaflet as exported from hospira australia
hospira cisplatin injection 100 mg/100 ml vial
hospira australia pty ltd - cisplatin, quantity: 1 mg/ml - injection - excipient ingredients: sodium hydroxide; hydrochloric acid; sodium chloride; mannitol; water for injections - cancer chemotherapeutic drug - details of the indications do not appear on the leaflet as exported from hospira australia
hospira levetiracetam concentrate for iv infusion levetiracetam 500 mg/5 ml concentrate for infusion vial
pfizer australia pty ltd - levetiracetam, quantity: 500 mg - injection, concentrated - excipient ingredients: nitrogen; sodium acetate trihydrate; sodium chloride; glacial acetic acid; water for injections - hospira? levetiracetam concentrate for iv infusion after dilution is an alternative for patients when oral administration is temporarily not feasible. levetiracetam is indicated for: use in epileptic patients aged 4 years and older, initially as add on therapy, in the treatment of partial onset seizures with or without secondary generalisation; monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy; add on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy and add on therapy in the treatment of primary generalized tonic-clonic seizures in adults and children from 4 years of age with idiopathic generalized epilepsy.
hospira vincristine sulfate 5mg/5ml injection vial
hospira australia pty ltd - vincristine sulfate, quantity: 1 mg/ml - injection, solution - excipient ingredients: mannitol; water for injections; sulfuric acid; sodium hydroxide - not applicable - to be used as part of the liposome injection kit. details are owned by the licence holder, not hospira.
hospira cefazolin sodium powder
hospira pty limited - cefazolin sodium -
hospira cefoxitin sodium powder for injection
hospira pty limited - cefoxitin sodium -
hospira ceftazidime powder for injection
hospira pty limited - ceftazidime pentahydrate; ceftazidime -